Patent · US Active

Compounds for targeting drug delivery and enhancing siRNA activity

US10100004B2 · kind B2 · utility

3Cited by
19References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2016
Grant dateOct 16, 2018
Priority date—
Expiry dateJun 8, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/907
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Here described are compounds consisting of the structure

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.